Baxter International (BAX) Stock Price & Analysis
$12.34B
Market Cap
-12.48
P/E
11.64
Forward P/E
32
Score
BAX price $23.87 -1.59 -6.25%
Stocklytics score rationale: value 48, quality 25, growth 22.
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 10163000000 | 10584000000 | 11099000000 | 11362000000 | 11673000000 | 12146000000 | 10057000000 | 10360000000 | 10636000000 | 11244000000 |
Baxter International Inc., operating globally via its subsidiaries, is a leading developer and provider of a wide spectrum of healthcare products. The company's comprehensive portfolio includes various dialysis treatments, such as peritoneal and hemodialysis, along with related therapies and services. It also specializes in intravenous (IV) therapies, infusion pumps, administration sets, and devices for drug…
Insights · Dividends · Forecast · Financials · Learn
$12.34B
Market Cap
-12.48
P/E
11.64
Forward P/E
32
Score